|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib显示文摘 | Hainsworth JD Sosman JA Spigel DR | 2005 | J Clin Oncol2005，23，31： | 1 |
| 2 | Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotini 显示文摘 | Hainsworth JD Sosman JA Spigel DR | 2005 | J Clin Omcol2005，23，22： | 1 |
| 3 | Opportunities and obsta- cles to combination targeted therapy in renal cell cancer显示文摘 | Sosman JA Puzanov I Atkins MB | 2007 | Clin Cancer Res2007，13，22： | 1 |
| 4 | Improving outcomes in patients with advanced renal cell carcinoma 显示文摘 | SOSMAN JA | 2008 | Expert Rev Antlcancer Ther2008，8，3： | 1 |
| 5 | Double- study of the combination of in patients with advanced melanoma: a report from the 11715 Study Group显示文摘 | McDermott DF Sosman JA blind randomized phase Ⅱ sorafenib and dacarbazine Gonzalez R | 2008 | J Clin Oncol2008，26，13： | 1 |
| 6 | BEAM:a ran- domized phase II sludy evaluating the activity of beva- cizumab in combination with carboplatin pluspaclitaxel in patients with previously untreated advanced melanoma显示文摘 | Kim KB Sosman JA Fruehauf JP | 2012 | J Clin Oncol2012，30，1： | 1 |
| 7 | Opportunities and obstacles to combination targeted therapy in renal cell cancer 显示文摘 | Sosman JA Puzanov I Atkins MB | 2007 | Clin Cancer Res2007，13，22： | 1 |
| 8 | Phase Ⅱ trial of bevacizumab and erlotinib in patients with metastasic renal carcinoma (RCC) 显示文摘 | Hainsworth JD Sosman JA Spigel DR | 2004 | Proc Am Soc Clin Oncol2004，23，： | 1 |
| 9 | Doubleblind randomized phase Ⅱ study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group 显示文摘 | McDermott DF Sosman JA Gonzalez R | 2008 | J Clin Oncol2008，26，13： | 1 |
| 10 | Doubleblind randomized phase Ⅰ study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group显示文摘 | McDermott DF Sosman JA Gonzalez R | 2008 | J Clin Oncol2008，26，13： | 1 |
| 11 | A phase 11 pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-alpha 2B in patients with metastatic melanoma显示文摘 | Atkins MB Gollob JA Sosman JA | 2002 | Clin Cancer Res2002，8，： | 1 |
| 12 | Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib 显示文摘 | Hainsworth JD Sosman JA Spigel DR | 2005 | J Clin Oncol2005，23，31： | 1 |
| 13 | Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: A report from the 11715 study group 显示文摘 | Mc Dermott DF Sosman JA Gonzalez R | 2008 | J Clin Oncol2008，26，13： | 1 |
| 14 | Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib显示文摘 | Hainsworth JD Sosman JA | 2005 | J Clin Oncol2005，23，31： | 1 |
| 15 | Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib显示文摘 | Sosman JA Kim KB Schuchter L | | 0，，8： | 1 |
| 16 | Phase II trial of bevacizumab and erlotinib in patients with metastatic renal carcinoma (RCC) 显示文摘 | Hainsworth JD Sosman JA Spigel DR | 2004 | Pro Am Soc Clin Oncol2004，22，： | 1 |
| 17 | Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: Biology, clinical results and future development显示文摘 | Rini BI Sosman JA Motzer RJ | 2005 | JBJU Int2005，96，1： | 1 |
| 18 | Safety and biological activity of repeated doses of recombinant human Flt3 ligand in patients with bone scan-negative hormone-refractory prostate cancer显示文摘 | Higano CS Vogelzang NJ Sosman JA | 2004 | Clinical Cancer Research2004，10，4： | 1 |
| 19 | Clinical activity,safety,and biomarkers of MPDL3280A,an engineered PD - LI antibody in patients with metastatic renal cell carcinoma ( mRCC )显示文摘 | Cho DC Sosman JA Sznol M | 2013 | J Clin Oncol2013，31，15： | 1 |
| 20 | Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study 显示文摘 | Atkins MB Sosman JA Agarwala S | 2008 | Cancer2008，113，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员